Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens (Q36813303)

16 August 2017

1 reference

title

Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens (English)

1 reference

16 August 2017

Brian J Morris

1

1 reference

16 August 2017

Barbara R Rose

series ordinal

2

1 reference

16 August 2017

publication date

1 January 2007

1 reference

Clinical Chemistry and Laboratory Medicine

16 August 2017

published in

1 reference

16 August 2017

volume

45

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

577-591

1 reference

The epidemiology of cervical cancer

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

International incidence rates of invasive cervical cancer before cytological screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

The 2001 Bethesda System: terminology for reporting results of cervical cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Methods for assessing the accuracy of PCR-based tests: comparisons and extensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

American Cancer Society guideline for the early detection of cervical neoplasia and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Liquid-based cytology for primary cervical cancer screening: a multi-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Liquid-based cytology - an alternative international view

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

An electronic approach to the detection of pre-cancer and cancer of the uterine cervix: a preliminary evaluation of Polarprobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: a multicenter evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Natural history of cervicovaginal papillomavirus infection in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus 16 infection in adenocarcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus in cervical screening and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Are some breast cancers sexually transmitted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Evidence for an association of human papillomavirus and breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Combined Pap and HPV testing in primary screening for cervical abnormalities: should HPV detection be delayed until age 35?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Clinical utility of HPV genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Chlamydia trachomatis infection and persistence of human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Papillomavirus screening of cervical lavages by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Polymerase chain reaction for fast, nonradioactive detection of high- and low-risk papillomavirus types in routine cervical specimens and in biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Automated polymerase chain reaction for papillomavirus screening of cervicovaginal lavages: comparison with dot-blot hybridization in a sexually transmitted diseases clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses (HPV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Multiplex nested PCR (MNP) assay for the detection of 15 high risk genotypes of human papillomavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Bead-based multiplex genotyping of human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Managing atypical squamous cells of undetermined significance (ASCUS): human papillomavirus testing, ASCUS subtyping,or follow-up cytology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Detection and genotyping of human papillomavirus in cervical samples from Italian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Prevalence and determinants of HPV infection among Colombian women with normal cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Detection of human papillomavirus infection of the cervix in very elderly women using PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Associations of high-risk HPV types and viral load with cervical cancer in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Detection of HPV-16 in cell lines and cervical lavage specimens by a polymerase chain reaction-enzyme immunoassay assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

A self-administered technique for the detection of sexually transmitted diseases in remote communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus (HPV) DNA detection in self-collected urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus PCR direct sequencing study of cervical precancerous lesions in Quebec children

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Human papillomavirus vaccines and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Prophylactic human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Strategies for the prevention of cervical cancer by human papillomavirus vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Risk compensation: the Achilles' heel of innovations in HIV prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Prevalence of HPV infection among females in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Cervical cancer control, priorities and new directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Could HPV testing become the sole primary cervical screening test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Parental acceptance of the human papillomavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

The Prevalence of the Human Papillomavirus in Cervix and Vagina in Low-risk and High-risk Populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Cervical Coinfection with Human Papillomavirus (HPV) Types and Possible Implications for the Prevention of Cervical Cancer by HPV Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Prevalence of human papillomavirus infection in women in Turin, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

Evaluation of commercial kits for the detection and typing of human papillomavirus in cervical swabs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.127

21 January 2018

Identifiers

DOI

10.1515/CCLM.2007.127

1 reference

16 August 2017

1 reference